Background: Pulmonary hypertension (PH) is a haemodynamic condition, secondary to different causes. Thalassaemia may lead to PH of different origin and needs a comprehensive analysis to be correctly characterized and possibly treated. Case summary: We present a case study of a patient with a non-transfusion-dependent thalassaemia and a previous diagnosis of group 5 PH. A complete diagnostic assessment led to a specific diagnosis of chronic thromboembolic PH. Thus, we were able to start a specific therapy with riociguat that provided an improvement in terms of haemodynamic, imaging, and functional status. Discussion: A correct characterization and treatment of PH are essential in order to change the patient's prognosis. Chronic thromboembolic PH is a treatable cause of PH in thalassemic patients and should be investigated.
The tailor-made treatment in a particular case of pulmonary hypertension in thalassaemia intermedia : A case report / F.B.M. Blasi, I. Rota, G. Graziadei, M. Vicenzi. - In: EUROPEAN HEART JOURNAL. CASE REPORTS. - ISSN 2514-2119. - 5:6(2021 Jun 16), pp. ytab193.1-ytab193.5. [10.1093/ehjcr/ytab193]
The tailor-made treatment in a particular case of pulmonary hypertension in thalassaemia intermedia : A case report
G. Graziadei;M. Vicenzi
Ultimo
2021
Abstract
Background: Pulmonary hypertension (PH) is a haemodynamic condition, secondary to different causes. Thalassaemia may lead to PH of different origin and needs a comprehensive analysis to be correctly characterized and possibly treated. Case summary: We present a case study of a patient with a non-transfusion-dependent thalassaemia and a previous diagnosis of group 5 PH. A complete diagnostic assessment led to a specific diagnosis of chronic thromboembolic PH. Thus, we were able to start a specific therapy with riociguat that provided an improvement in terms of haemodynamic, imaging, and functional status. Discussion: A correct characterization and treatment of PH are essential in order to change the patient's prognosis. Chronic thromboembolic PH is a treatable cause of PH in thalassemic patients and should be investigated.File | Dimensione | Formato | |
---|---|---|---|
ytab193.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
362.36 kB
Formato
Adobe PDF
|
362.36 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.